Global /Australia /Healthcare /Medical Devices /ADRDA

Adherium Ltd.

ADRDA (ADR)

• ASX: ADRDA • Delayed

0.0020AUD 0%

0.0014 USD

As of 5 June 2026, Adherium Ltd. has a market cap of $7.67M USD, ranking #42642 globally and #1422 in Australia. It ranks #3771 in the Healthcare sector, and #790 in the Medical Devices industry.

Global Rank

42642

Country Rank

1422

Sector Rank

3771

Industry Rank

790

Key Stats

Market Cap

$7.67MUSD

10.75M AUD

Enterprise Value

$8.16MUSD

11.43M AUD

Revenue (TTM)

$798.06KUSD

1.12M AUD

EBITDA (TTM)

-$8.81MUSD

-12.34M AUD

Net Income (TTM)

-$9.11MUSD

-12.76M AUD

PS Ratio

9.6

PB Ratio

-13.7

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Medical Devices

CEO

Dawn Bitz open_in_new

Employees

Founded

2001

Website

adherium.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-20%	0%	-69%	-56%	-60%	-78%	-96%	-99%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	ADRDA (ADR) Adherium Ltd ISIN: AU000000ADR1 Shares Out.: Shares Outstanding: 5.374B¹ Shares Float: 4.807B² TV: TradingView: ASX: ADRDA SA: Stock Analysis: ASX: ADRDA YF: Yahoo Finance: ADRDA.AX GF: Google Finance: ASX: ADRDA BA: Barron's: ADRDA MS: Morningstar: XASX: ADRDA	0.0020 AUD	TV: TradingView: ASX: ADRDA SA: Stock Analysis: ASX: ADRDA YF: Yahoo Finance: ADRDA.AX GF: Google Finance: ASX: ADRDA BA: Barron's: ADRDA MS: Morningstar: XASX: ADRDA

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Adherium Ltd.

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides Hailie Smartinhaler sensors; Hailie Solution; and Hailie Remote Patient Monitoring (RPM) Solution. The company was founded in 2001 and is based in Melbourne, Australia.

Similar Companies

Industry: Medical Devices (Australia)

Name	Market Cap (USD) diff.	PE	Country
Cochlear Ltd. ASX: COH	$4.2B 5.89B AUD 55K%	17.1	Australia
EBOS Group Ltd. NZE: EBO	$2.55B 4.34B NZD 33K%	16.0	Australia
Clarity Pharmaceuticals Ltd. ASX: CU6	$786.34M 1.1B AUD 10K%	-	Australia
Nanosonics Ltd. ASX: NAN	$743.12M 1.04B AUD 10K%	52.3	Australia
Tetratherix Ltd. ASX: TTX	$171.0M 239.61M AUD 2K%	-	Australia
Orthocell Ltd. ASX: OCC	$170.38M 238.75M AUD 2K%	-	Australia

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 2M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 2M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 2M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 2M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 2M%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 1M%	22.2	Ireland

chevron_leftBack